Procalcitonin: A new marker of inflammation in haemodialysis patients?

Nephrology Dialysis Transplantation

Volumn 16, Issue 5, 2001, Pages 980-986

  Level, Claude ^a   Chauveau, Philippe ^a   Delmas, Yahsou ^a   Lasseur, Catherine ^a   Pellé, Gaëlie ^a   Peuchant, Evelyne ^a   Montaudon, Danièle ^b   Combe, Christian ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

Acute phase proteins; Albumin; C reactive protein; Haemodialysis; Inflammation; Interleukin 6; Procalcitonin

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; FIBRINOGEN; HEMOGLOBIN; INTERLEUKIN 6; PREALBUMIN; PROCALCITONIN; RECOMBINANT ERYTHROPOIETIN; UREA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIALYSIS MEMBRANE; DISEASE MARKER; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INFECTION; INFLAMMATION; KIDNEY FAILURE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0035025257     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.5.980     Document Type: Article

References (33)

1. Bergström J, Lindholm B. Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis 1998; 32: 834-841
2. Lacson K, Owen W. Interactions between hemodialysis adequacy and nutrition in dialysis patients. Semin Dial 1999; 12: 112-116
3. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-436
4. Stevenson F. Inflammation and end stage renal disease: recent insights. Semin Dial 1998; 11: 119-123
5. Lowrie E, Huang W, Lew N. Death risk predictors among peritoneal dialysis and hemodialysis patients: a preliminary comparison. Am J Kidney Dis 1995; 26: 220-228
6. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658
7. Bologa RM, Levine DM, Parker TS et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in haemodialysis patients. Am J Kidney Dis 1998; 32: 107-114
8. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance haemodialysis patients. Kidney Int 1998; 54: 627-636
9. Bossink A, Groeneveld J, Lambertus G. Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha-antitrypsin and lacto-ferrin compared with clinical variables. Clin Inject Dis 1999; 29: 398-407
10. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-518
11. al-Nawas B, Shah PM. Procalcitonin in patients with and without immunosuppression and sepsis. Infection 1996; 24: 434-436
12. Bernard L, Ferriere F, Casassus P et al. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 1998; 27: 914-915
13. Schwenger V, Sis J, Breitbart A, Andrassy K. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection 1998; 26: 274-276
14. NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1997; 30 [4 Suppl 3]: S15-66
15. Schiller N, Shah P, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards. Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367
16. The USRDS dialysis morbidity and mortality study (Wave 1). Am J Kidney Dis 1996; 28: S58-78
17. Herbelin A, Urena P, Nguyen AT, Zingraff J, Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991; 39: 954-960
18. Aparicio M, Cano N, Chauveau P et al. Nutritional status of haemodialysis patients: a French national cooperative study. Nephrol Dial Transplant 1999; 14: 1679-1686
19. Lowrie EG, Lew NL. Death risk in haemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482
20. Cano N, Stroumza P, Lacombe P, Labastie-Coeyrehourcq J. Plasma prealbumin in haemodialysis patients. Am J Kidney Dis 1994; 23: 621
21. Foley R, Parffey P, Harnett J, Kent G, Murray D, Barre P. Hypoalbuminemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728-736
22. Arora P, Strauss BJ, Borovnicar D, Stroud D, Atkins RC, Kerr PG. Total body nitrogen predicts long-term mortality in haemodialysis patients-a single-centre experience. Nephrol Dial Transplant 1998; 13: 1731-1736
23. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM. Association of morbidity with markers of nutrition and inflammation in chronic haemodialysis patients: a prospective study. Kidney Int 1999; 55: 1945-1951
24. Oczenski W, Fitzgerald RD, Schwarz S. Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period. Eur J Anaesth 1998; 15: 202-209
25. Zeni F, Viallon A, Assicot M. Tardy B et al. Procalcitonin serum concentrations and severity of sepsis. Clin Intens Care 1994; 5 [Suppl 2]: 89-98
26. Eberhard OK, Langefeld I, Kuse ER, Brunkhorst FM, Kliem V, Schlitt HJ and al. Procalcitonin in the early phase after renal transplantation-will it add to diagnostic accuracy? Clin Transplant 1998; 12: 206-211
27. Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250-1256
28. Ulrich C, Keil K, Hermann W, Kuhlmann M et al. Procalcitonin: a further acute phase parameter in patients undergoing haemodialysis. J Am Soc Nephrol 2000; 11: 501A
29. Nishikura T. The clearance of procalcitonin during continuous venovenous hemodiafiltration. Intensive Care Med 1999; 25: 1198-1201
30. Kaizu Y, Kimura M, Yoneyama T, Miyaji K, Hibi I, Kumagai H. Interleukin-6 may mediate malnutrition in chronic haemodialysis patients. Am J Kidney Dis 1998; 31: 93-100
31. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
32. Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in haemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999; 33: 63-72
33. Barany P, Divino Filho JC, Bergström J. High C-reactive protein is a strong predictor of resistance to erythropoietin in haemodialysis patients. Am J Kidney Dis 1997; 29: 565-568